These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4836957)

  • 1. [The cutaneous vasoconstriction test in man as a means of evaluating topical corticoids. II. Cutaneous vasoconstrictive effects of topical corticoids in tests devised by various investigators (author's transl)].
    Lutz U; Weirich EG
    Dermatologica; 1974; 148(3):160-74. PubMed ID: 4836957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. IV. Time slope of vasoconstriction and reactive vasodilatation (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):43-50. PubMed ID: 1259465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. V. Vasoconstriction phaenomenon and tachyphylaxis after repeated steroid application (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):51-6. PubMed ID: 1259466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking of topical glucocorticoids. Principles and results.
    Smith EW; Haigh JM
    Curr Probl Dermatol; 1993; 21():89-96. PubMed ID: 8299381
    [No Abstract]   [Full Text] [Related]  

  • 6. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Clin Exp Dermatol; 1983 Sep; 8(5):489-93. PubMed ID: 6641007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of the vasoconstriction assay and clinical activity in psoriasis.
    Cornell RC; Stoughton RB
    Arch Dermatol; 1985 Jan; 121(1):63-7. PubMed ID: 3881088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On an improved device for measuring skin tearing strength. Technical description and experimental results obtained from rat skin following therapy with topical corticoids (author's transl)].
    Weishaupt W; Mengel K; Josefiuk P; Kapp JF
    Arzneimittelforschung; 1977; 27(11a):2203-6. PubMed ID: 580029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
    Reckers R; Wendt H
    Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic topical corticosteroids.
    Med Lett Drugs Ther; 1988 May; 30(765):49-50. PubMed ID: 3362092
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the question of interval application of topical corticoids/Practicability and efficacy (author's transl)].
    Schmitz H; Flinzer E
    Arzneimittelforschung; 1982; 32(4):430-7. PubMed ID: 7201816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostaglandin release by antiinflammatory steroids.
    Lewis GP; Piper PJ
    Adv Prostaglandin Thromboxane Res; 1976; 1():121-4. PubMed ID: 187032
    [No Abstract]   [Full Text] [Related]  

  • 14. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 15. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 16. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution to the testing of the action of external corticoids in a comparative human pharmacological test].
    Friderich H
    Arztl Forsch; 1966 Oct; 20(10):549-52. PubMed ID: 5953717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of topical corticosteroid activity by skin inflammatory tests].
    Tagliavini R; Colombi A
    Boll Chim Farm; 1972 Feb; 111(2):116-25. PubMed ID: 5045533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Skin tolerance of topical corticoids as dependent upon the pH value of the emulsions].
    Koch E; Loebich F; Frosch PJ
    Derm Beruf Umwelt; 1983; 31(4):122-6. PubMed ID: 6628235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.